Ocular findings in children with acute leukemia at a tertiary care center in South America

PURPOSE: The purpose of this study was to evaluate ophthalmological findings in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in a Latin American population. MATERIALS AND METHODS: This was a single-center, retrospective study. The observational analysis was condu...

Full description

Bibliographic Details
Main Authors: Franco Benvenuto, Mariana Sgroi, Soledad S Guillen, David Ancona, Adriana Fandiño
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Oman Journal of Ophthalmology
Subjects:
Online Access:http://www.ojoonline.org/article.asp?issn=0974-620X;year=2022;volume=15;issue=2;spage=159;epage=162;aulast=Benvenuto
_version_ 1818509376050167808
author Franco Benvenuto
Mariana Sgroi
Soledad S Guillen
David Ancona
Adriana Fandiño
author_facet Franco Benvenuto
Mariana Sgroi
Soledad S Guillen
David Ancona
Adriana Fandiño
author_sort Franco Benvenuto
collection DOAJ
description PURPOSE: The purpose of this study was to evaluate ophthalmological findings in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in a Latin American population. MATERIALS AND METHODS: This was a single-center, retrospective study. The observational analysis was conducted in AML and ALL patients seen as a routine examination at the department of ophthalmology of tertiary care center in Argentina between March 1, 2017, and February 28, 2018. RESULTS: Overall, 137 patients with acute leukemia were included. The mean age was 7.9 ± 5.2 years (0–18), and 55% were male (n = 75) and 45% female (n = 45). At least one-fifth (n = 31) of the patients presented some type of ocular manifestation (23%). The most frequently observed manifestation was retinal hemorrhages (n = 14), followed by papilledema (n = 9) and ocular surface involvement (n = 5). The eye involvement was more frequently identified in the AML group (24%), compared to the ALL group (22%), especially papilledema with central nervous system compromise ALL (5%) and AML (11%), P < 0.01. The presence of hemorrhages was similar in both groups. In patients with retinal hemorrhage (n = 14), the mean hematological findings were hemoglobin 7.4 ± 0.4 g/dL (6.5–8.0), erythrocytes 2.5M ± 0.3/mm3 (confidence interval [CI], 2.0–3.1), and platelets 76,000 ± 32,000/mm3 (CI, 8000–384,000). Patients without retinal findings (n = 123), the mean hematological findings were hemoglobin 9.1 ± 0.6 g/dL (8.0–10.2), erythrocytes 3.2M ± 0.6/mm3 (CI, 2.5–3.5), and platelets 92,000 ± 44,000/mm3 (CI, 42.000–390.000). Multivariable analysis found that hemoglobin levels were the most reliable predictive factor for retinal findings. It was observed that the risk diminishes in patients with levels higher than 8.5 g/dL, and that it increased in patients with levels ranging between 6.5 and 7.5 g/dL at least twice (P < 0.01). CONCLUSIONS: Our results show that ocular involvement occurs in a high percentage of patients with leukemia with a clear clinical, humoral, and sometimes prognostic correlation, suggesting routine ophthalmologic evaluation in these patients.
first_indexed 2024-12-10T22:44:41Z
format Article
id doaj.art-d2101f24e8cf44a88310b68a927605df
institution Directory Open Access Journal
issn 0974-620X
language English
last_indexed 2024-12-10T22:44:41Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Oman Journal of Ophthalmology
spelling doaj.art-d2101f24e8cf44a88310b68a927605df2022-12-22T01:30:37ZengWolters Kluwer Medknow PublicationsOman Journal of Ophthalmology0974-620X2022-01-0115215916210.4103/ojo.ojo_347_20Ocular findings in children with acute leukemia at a tertiary care center in South AmericaFranco BenvenutoMariana SgroiSoledad S GuillenDavid AnconaAdriana FandiñoPURPOSE: The purpose of this study was to evaluate ophthalmological findings in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in a Latin American population. MATERIALS AND METHODS: This was a single-center, retrospective study. The observational analysis was conducted in AML and ALL patients seen as a routine examination at the department of ophthalmology of tertiary care center in Argentina between March 1, 2017, and February 28, 2018. RESULTS: Overall, 137 patients with acute leukemia were included. The mean age was 7.9 ± 5.2 years (0–18), and 55% were male (n = 75) and 45% female (n = 45). At least one-fifth (n = 31) of the patients presented some type of ocular manifestation (23%). The most frequently observed manifestation was retinal hemorrhages (n = 14), followed by papilledema (n = 9) and ocular surface involvement (n = 5). The eye involvement was more frequently identified in the AML group (24%), compared to the ALL group (22%), especially papilledema with central nervous system compromise ALL (5%) and AML (11%), P < 0.01. The presence of hemorrhages was similar in both groups. In patients with retinal hemorrhage (n = 14), the mean hematological findings were hemoglobin 7.4 ± 0.4 g/dL (6.5–8.0), erythrocytes 2.5M ± 0.3/mm3 (confidence interval [CI], 2.0–3.1), and platelets 76,000 ± 32,000/mm3 (CI, 8000–384,000). Patients without retinal findings (n = 123), the mean hematological findings were hemoglobin 9.1 ± 0.6 g/dL (8.0–10.2), erythrocytes 3.2M ± 0.6/mm3 (CI, 2.5–3.5), and platelets 92,000 ± 44,000/mm3 (CI, 42.000–390.000). Multivariable analysis found that hemoglobin levels were the most reliable predictive factor for retinal findings. It was observed that the risk diminishes in patients with levels higher than 8.5 g/dL, and that it increased in patients with levels ranging between 6.5 and 7.5 g/dL at least twice (P < 0.01). CONCLUSIONS: Our results show that ocular involvement occurs in a high percentage of patients with leukemia with a clear clinical, humoral, and sometimes prognostic correlation, suggesting routine ophthalmologic evaluation in these patients.http://www.ojoonline.org/article.asp?issn=0974-620X;year=2022;volume=15;issue=2;spage=159;epage=162;aulast=Benvenutoleukemiaocular oncologypediatric retina
spellingShingle Franco Benvenuto
Mariana Sgroi
Soledad S Guillen
David Ancona
Adriana Fandiño
Ocular findings in children with acute leukemia at a tertiary care center in South America
Oman Journal of Ophthalmology
leukemia
ocular oncology
pediatric retina
title Ocular findings in children with acute leukemia at a tertiary care center in South America
title_full Ocular findings in children with acute leukemia at a tertiary care center in South America
title_fullStr Ocular findings in children with acute leukemia at a tertiary care center in South America
title_full_unstemmed Ocular findings in children with acute leukemia at a tertiary care center in South America
title_short Ocular findings in children with acute leukemia at a tertiary care center in South America
title_sort ocular findings in children with acute leukemia at a tertiary care center in south america
topic leukemia
ocular oncology
pediatric retina
url http://www.ojoonline.org/article.asp?issn=0974-620X;year=2022;volume=15;issue=2;spage=159;epage=162;aulast=Benvenuto
work_keys_str_mv AT francobenvenuto ocularfindingsinchildrenwithacuteleukemiaatatertiarycarecenterinsouthamerica
AT marianasgroi ocularfindingsinchildrenwithacuteleukemiaatatertiarycarecenterinsouthamerica
AT soledadsguillen ocularfindingsinchildrenwithacuteleukemiaatatertiarycarecenterinsouthamerica
AT davidancona ocularfindingsinchildrenwithacuteleukemiaatatertiarycarecenterinsouthamerica
AT adrianafandino ocularfindingsinchildrenwithacuteleukemiaatatertiarycarecenterinsouthamerica